Advanced glycation end products receptor RAGE controls myocardial dysfunction and oxidative stress in high-fat fed

Yichi Yu1, Lei Wang1, Florian Delguste2

  • 1INSERM U995, LIRIC /Team "Glycation: from inflammation to aging", Lille University, France; School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Insights

Mice lacking the receptor for advanced glycation end products (RAGE) show improved heart function despite a high-fat diet. This protection involves enhanced antioxidant capacity and better mitochondrial quality control through autophagy.

Area of Science:

  • Cardiovascular biology
  • Mitochondrial medicine
  • Metabolic disease research

Background:

  • Oxidative stress and mitochondrial dysfunction contribute to cardiovascular damage in diabetes and high-fat diets (HFD).
  • Blockade of the receptor for advanced glycation end products (RAGE) reduces vascular oxidative stress and atherosclerosis.

Purpose of the Study:

  • To investigate if RAGE deficiency reverses HFD-induced myocardial dysfunction.
  • To examine changes in oxidative stress, mitochondrial respiration, fission, and autophagy-lysosomal pathways in RAGE-deficient mice on an HFD.

Main Methods:

  • Comparison of wild-type and RAGE-deficient mice on normal and high-fat diets.
  • Assessment of cardiac antioxidant capacity, mitochondrial dynamics (fission proteins), and autophagy-lysosomal pathway markers.
  • Evaluation of mitochondrial respiration and cardiac contractile function.

Main Results:

  • RAGE-deficient mice exhibited upregulated cardiac antioxidant capacity and increased mitochondrial fragmentation with enhanced autophagy markers.
  • HFD induced mitochondrial dysfunction, contractile deficits, and autophagy inhibition in wild-type mice, effects partially prevented in RAGE-deficient mice.
  • Inhibition of autophagy worsened HFD effects, while stimulation improved function in wild-type mice, indicating autophagy's crucial role.

Conclusions:

  • RAGE deficiency confers cardioprotection against HFD, involving autophagy reactivation and improved mitochondrial quality control via enhanced fission-mediated mitophagy.
  • Modulating the RAGE pathway may offer a therapeutic strategy for mitigating mitochondrial damage and myocardial dysfunction in HFD-induced conditions.